Horizon Space Acquisition II Corp. (HSPT) is a Blank Checks company listed on NASDAQ. There were no new wire items for HSPT in the last 30 days. The most recent was published Aug 13, 2026.
News · 26 weeks130%
2026-05-102026-11-01
Mix290d
- Other2(100%)
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by Horizon Space Acquisition II Corp.SCHEDULE 13G/A - Horizon Space Acquisition II Corp. (0002032950) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Horizon Space Acquisition II Corp.SCHEDULE 13G/A - Horizon Space Acquisition II Corp. (0002032950) (Subject)
- SECSEC Form 15-12G filed by Horizon Space Acquisition II Corp.15-12G - Horizon Space Acquisition II Corp. (0002032950) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Horizon Space Acquisition II Corp.SCHEDULE 13D/A - Horizon Space Acquisition II Corp. (0002032950) (Subject)
- INSIDERSEC Form 4 filed by Chief Executive Officer Li Mingyu4 - Horizon Space Acquisition II Corp. (0002032950) (Issuer)
- INSIDERSEC Form 4 filed by Director Cai Tianchen4 - Horizon Space Acquisition II Corp. (0002032950) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Zhai Min4 - Horizon Space Acquisition II Corp. (0002032950) (Issuer)
- INSIDERSEC Form 4 filed by Director Xu Qian4 - Horizon Space Acquisition II Corp. (0002032950) (Issuer)
- SECSEC Form 25-NSE filed by Horizon Space Acquisition II Corp.25-NSE - Horizon Space Acquisition II Corp. (0002032950) (Subject)
- PRSL BIO Ltd. and Horizon Space Acquisition II Announce Closing of Business Combination and Listing on the Nasdaq Global MarketPost-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol "SLBT"Transaction provides strategic capital to advance proprietary Gamma delta T cell-based "off-the-shelf" cellular therapies for solid tumor indications, including pancreatic and brain cancersLeadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. ("SL Bio" or the "Company"), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the closi
- SECSEC Form 10-Q filed by Horizon Space Acquisition II Corp.10-Q - Horizon Space Acquisition II Corp. (0002032950) (Filer)
- SECSEC Form NT 10-Q filed by Horizon Space Acquisition II Corp.NT 10-Q - Horizon Space Acquisition II Corp. (0002032950) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Horizon Space Acquisition II Corp.SCHEDULE 13G/A - Horizon Space Acquisition II Corp. (0002032950) (Subject)
- SECHorizon Space Acquisition II Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Horizon Space Acquisition II Corp. (0002032950) (Filer)
- SECSEC Form 10-K filed by Horizon Space Acquisition II Corp.10-K - Horizon Space Acquisition II Corp. (0002032950) (Filer)
- SECSEC Form NT 10-K filed by Horizon Space Acquisition II Corp.NT 10-K - Horizon Space Acquisition II Corp. (0002032950) (Filer)
- SECSEC Form 425 filed by Horizon Space Acquisition II Corp.425 - Horizon Space Acquisition II Corp. (0002032950) (Subject)
- SECSEC Form 425 filed by Horizon Space Acquisition II Corp.425 - Horizon Space Acquisition II Corp. (0002032950) (Subject)
- SECHorizon Space Acquisition II Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - Horizon Space Acquisition II Corp. (0002032950) (Filer)
- SECHorizon Space Acquisition II Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Horizon Space Acquisition II Corp. (0002032950) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Horizon Space Acquisition II Corp.SCHEDULE 13G/A - Horizon Space Acquisition II Corp. (0002032950) (Subject)
- SECHorizon Space Acquisition II Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - Horizon Space Acquisition II Corp. (0002032950) (Filer)
- SECSEC Form 425 filed by Horizon Space Acquisition II Corp.425 - Horizon Space Acquisition II Corp. (0002032950) (Subject)
- SECHorizon Space Acquisition II Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Horizon Space Acquisition II Corp. (0002032950) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Horizon Space Acquisition II Corp.SCHEDULE 13G/A - Horizon Space Acquisition II Corp. (0002032950) (Subject)
HSPT FAQ
6 questionsWhat is the latest news on HSPT?
Quantisnow has not tracked any new filings, ratings or press releases for HSPT in the last 30 days. The most recent wire item was published on August 13, 2026.Where does HSPT stock trade?
Horizon Space Acquisition II Corp. (HSPT) is listed on NASDAQ.What sector and industry is HSPT in?
Horizon Space Acquisition II Corp. operates in the Finance sector, Blank Checks industry.When did Horizon Space Acquisition II Corp. go public?
Horizon Space Acquisition II Corp. (HSPT) completed its IPO in 2025.What companies are similar to HSPT?
Notable peers in the same industry include TACO (Berto Acquisition Corp.), PRE (Prenetics Global Limited), OXSQ (Oxford Square Capital Corp.), ILLU (Illumination Acquisition Corp I), INV (Innventure Inc.). Compare HSPT side-by-side with any of them on Quantisnow.How can I track HSPT on Quantisnow?
Quantisnow aggregates Horizon Space Acquisition II Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HSPT to receive live email and push alerts on every new disclosure.